Abstract: Methods and systems are provided for sample preparation techniques and sequencing of macromolecular constituents of cells and other biological materials.

Abstract: A case for an electronic device can include a case body including an exterior surface and an interior surface, the interior surface being positioned opposite the exterior surface. The case can additionally include a button body positioned at least partially within the case body between the exterior surface and the interior surface, the button body being movable inward and outward relative to the case body along an axis of button travel. The case can further include a biasing structure having a contact surface configured to contact the button body, the biasing structure configured to bias the button body toward the interior surface along the axis of button travel.

Abstract: Disclosed are systems and methods for a network framework for Wi-Fi barring of network usage that enables network management at a device level, which provides capabilities for the optimization of internet connectivity and data usage based on a user's and/or device's specific needs and priorities. The framework operates to handle information management system (IMS) connections and IMS registration failures over evolved Packet Data Gateways (ePDG). The framework provides a Wi-Fi backoff timer that can be implemented for particular Wi-Fi networks, which can correspond to a Wi-Fi access point (AP). Thus, a connected device (e.g., a user's smart phone) can toggle connectivity to and/or from a cellular network in accordance with encountered failures with an AP via the timer's implementation and network control of the device.

Abstract: The present invention relates to compounds having activity at both the human glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The present invention also relates to compounds having an extended duration of action at each of these receptors. Furthermore, the present invention relates to compounds that may be administered orally. Compounds may be useful in the treatment of type 2 diabetes mellitus (“T2DM”). Also, the compounds may be useful in the treatment of obesity.

Abstract: Curved seatback monitors or display screens, and associated systems, devices, and methods for providing wide view display monitor technology on a commercial passenger vehicle are disclosed herein. An in-flight entertainment and communication (IFEC) system can be installed on a passenger vehicle having an aisle, window seats along a first side of the aisle, and center seats along a second side of the aisle. In some embodiments, the IFEC system includes a plurality of display screens positioned in front of corresponding ones of the seats. Each display screen can include a first portion having a first curvature radius and a second portion having a second curvature radius greater than the first curvature radius. The second portions of the display screens can be positioned closer to the aisle than the first portions. The curved display screens and the arrangement thereof are expected to improve passenger experience.

Abstract: Antigen binding molecules (ABMs) comprising Fab domains in non-native configurations, ABM conjugates comprising the ABMs and cytotoxic or cytostatic agents, pharmaceutical compositions containing the ABMs and ABM conjugates, methods of using the ABMs, ABM conjugates and pharmaceutical compositions for treating cancer, nucleic acids encoding the ABMs, cells engineered to express the ABMs, and methods of producing ABMs.

Abstract: Methods and systems are provided for sample preparation techniques and sequencing of macromolecular constituents of cells and other biological materials.

Abstract: Methods and systems are provided for sample preparation techniques and sequencing of macromolecular constituents of cells and other biological materials.

Abstract: The present invention provides a method for manufacturing a compound of formula (I) or a pharmaceutically acceptable salt thereof; wherein R1 R2, R4 and X1 are defined herein.

Abstract: The present invention relates to crosslinkable ink compositions and the preparation and use thereof.

Abstract: An architecture to perform resource management among multiple network nodes and associated resources is disclosed. Example resource management techniques include those relating to: proactive reservation of edge computing resources; deadline-driven resource allocation; speculative edge QOS pre-allocation; and automatic QoS migration across edge computing nodes.

Abstract: The present invention relates to compounds having activity at both the human glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The present invention also relates to compounds having an extended duration of action at each of these receptors. Furthermore, the present invention relates to compounds that may be administered orally. Compounds may be useful in the treatment of type 2 diabetes mellitus (“T2DM”). Also, the compounds may be useful in the treatment of obesity.

Abstract: An inbound message including medical record content may be received. The inbound message may indicate a healthcare entity and a vendor entity. It may be determined, from the healthcare entity and stored correspondences between medical record formats and healthcare entities, that the medical record content of the inbound message is in a first medical record format. Which configuration record of stored configuration records specifying combinations of sets of rules may be determined to apply as a translation to the inbound message based upon the medical record content of the inbound message and the first medical record format. The sets of rules as indicated by the configuration record may be accessed and applied to the inbound message to translate the medical record content in the inbound message from the first medical record format to the standardized format. The standardized format may be transmitted to the vendor entity.

Abstract: A method of making a reinforcement part for a vehicle includes applying a release film directly onto a surface of the vehicle, applying a first metallic layer directly or indirectly onto the release film, applying a curable bonding layer directly onto the first metallic layer, and applying a second metallic layer directly onto the curable bonding layer. The method also includes applying pressure to the first metallic layer, the curable bonding layer, and the second metallic layer so that the first metallic layer, the curable bonding layer, and the second metallic layer are compressed against the surface. The method further includes curing the curable bonding layer when pressure is applied to the curable bonding layer to form the reinforcement part. The method additionally includes, after curing the curable bonding layer, removing the reinforcement part from the surface.

Abstract: A data processing system implements receiving a first input in a spreadsheet in a spreadsheet application, detecting an indication that the first input includes first executable program code, analyzing the first executable program code to identify first references to one or more first elements of the spreadsheet in the first executable program code, requesting spreadsheet data associated with the one or more first elements of the spreadsheet from the spreadsheet application, receiving the spreadsheet data from the spreadsheet application; executing the first executable program code using the spreadsheet data referenced in the first executable program code to obtain a first program code result and causing the spreadsheet application to display the first program code result in the spreadsheet application.

Abstract: The present invention relates to compounds having activity at both the human glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. The present invention also relates to compounds having an extended duration of action at each of these receptors. Furthermore, the present invention relates to compounds that may be administered orally. Compounds may be useful in the treatment of type 2 diabetes mellitus (“T2DM”). Also, the compounds may be useful in the treatment of obesity.

Abstract: Systems and methods for object-based content recommendation are described. A camera feed comprising a plurality of image frames is caused to be displayed at a client device. An object is detected within an image frame from the camera feed, the object corresponding with an object category. Responsive to detecting the object, an icon associated with the object category is selected and displayed at a position upon the camera feed. The icon corresponds with a media collection related to the object category. An input is received selecting the icon. Responsive to the input, a presentation of media items from the media collection is displayed at the client device. By detecting real-world objects and surfacing relevant virtual icons that link to associated media, an augmented reality experience is provided allowing virtual content to be overlaid and anchored to objects in reality.

Abstract: Antigen binding molecules (ABMs) comprising Fab domains in non-native configurations, ABM conjugates comprising the ABMs and cytotoxic or cytostatic agents, pharmaceutical compositions containing the ABMs and ABM conjugates, methods of using the ABMs, ABM conjugates and pharmaceutical compositions for treating cancer, nucleic acids encoding the ABMs, cells engineered to express the ABMs, and methods of producing ABMs.

Abstract: There are provided measures for enabling dynamic remote malware scanning. Such measures could exemplarily include identification of an electronic file to be scanned for malware, generation of at least one scanning object of the identified electronic file on the basis of a dynamic configuration by a remote entity, said at least one scanning object being generated by using malware-susceptible data of the identified electronic file and neglecting malware-insusceptible data of the identified electronic file, transfer of the at least one scanning object of the identified electronic file for remote malware scanning to the remote entity, and execution of a malware scan of the at least one scanning object of the electronic file at the remote entity by a malware scanning engine or application.